PAUL J HASTINGS Insider Trading $OMED OncoMed Pharmaceuticals Inc

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PAUL J HASTINGS.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PAUL J HASTINGS. PAUL J HASTINGS is President & CEO in QLT INC/BC ($QLTI) and Chairman & CEO in OncoMed Pharmaceuticals Inc ($OMED) and Chief Executive Officer in OncoMed Pharmaceuticals Inc ($OMED) and Director in PROTEON THERAPEUTICS INC ($PRTO) and Director in Pacira Pharmaceuticals, Inc. ($PCRX) and Director in Relypsa Inc ($RLYP) and Chief Executive Officer in Nkarta, Inc. ($NKTX) and See Remarks in Nkarta, Inc. ($NKTX).

PAUL J HASTINGS in OncoMed Pharmaceuticals Inc

Trading Symbol: OMED
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL J HASTINGS: Chairman & CEO, Chief Executive Officer
Holdings: 77,534 shares
Current Value: $634,228
Latest Transaction: Oct 12 2017
$OMED Market Capitalization: $294.51M
$OMED Previous Close: $8.18

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of PAUL J HASTINGS in OncoMed Pharmaceuticals Inc

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, NKTX, NVLN, OMED, PCRX, TARA, RLYP

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 12 2017OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOSellS4.241,3465,70976,18877.5 K to 76.2 K (-1.74 %)
Oct 12 2017OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOSellS4.265222277,53477.6 K to 77.5 K (-0.07 %)
Apr 25 2017OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOOption ExerciseA3.77135,000508,950135,000
Apr 25 2017OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOGrantA0.0045,000077,58632.6 K to 77.6 K (+138.10 %)
Apr 05 2017OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOSellS9.066,42558,19932,58639 K to 32.6 K (-16.47 %)
Apr 05 2017OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOSellS8.874842639,01139.1 K to 39 K (-0.12 %)
Jan 09 2017OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOOption ExerciseM1.4321,36930,5580
Jan 09 2017OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOOption ExerciseM1.4321,36930,55821,369
Jan 09 2017OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOSellS8.5221,369181,95737,32358.7 K to 37.3 K (-36.41 %)
Jan 09 2017OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOBuyM1.4321,36930,55858,69237.3 K to 58.7 K (+57.25 %)
Jan 09 2017OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOSellS8.1721,369174,60237,32358.7 K to 37.3 K (-36.41 %)
Jan 09 2017OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOBuyM1.4321,36930,55858,69237.3 K to 58.7 K (+57.25 %)
Jan 05 2017OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOOption ExerciseA7.66176,0001,348,160176,000
Oct 11 2016OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOGrantA0.0014,000037,32323.3 K to 37.3 K (+60.03 %)
Jan 08 2016OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOSellS21.54771,65922,02522.1 K to 22 K (-0.35 %)
Jan 08 2016OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChairman & CEOSellS22.302,33552,07222,10224.4 K to 22.1 K (-9.56 %)
Dec 29 2015OMEDOncoMed Pharmaceut ...HASTINGS PAUL JChief Executive Off ...Option ExerciseA21.43170,0003,643,100170,000

Page:   1

Contact us | Follow us on Twitter